Responses in patients receiving sequential paclitaxel post progression on PD1 inhibitors. (May 2018)

• Record Type: Journal Article
• Authors: Sukari, Ammar; Nagasaka, Misako; Abdallah, Nadine
• Is Part Of: Oral oncology. Volume 80(2018)
• Page Start: 100
• Page End: 102
• Publication Date: 2018-05
• Subjects: Chemoimmunotherapy -- Synergy -- Taxanes -- Pembrolizumab -- Head and neck squamous cell carcinoma; Mouth -- Cancer -- Periodicals; Mouth -- Tumors -- Periodicals; Mouth Diseases -- Periodicals; Mouth Neoplasms -- Periodicals; Bouche -- Cancer -- Périodiques; Bouche -- Tumeurs -- Périodiques; Tumeurs -- Périodiques; Electronic journals; 616.9943105
• DOI: 10.1016/j.oraloncology.2018.03.011
• Languages: English
• ISSNs: 1368-8375

Abstract

Abstract: This report describes highlights the dramatic responses seen in patients who were given paclitaxel post progression on immunotherapy. There are multiple mechanisms by which synergistic effects of immunotherapy and chemotherapy occur. Further prospective studies on chemotherapy and immunotherapy are eagerly awaited.